Sedizorin en es it fr

Sedizorin Brand names, Sedizorin Analogs

Sedizorin Brand Names Mixture

  • No information avaliable

Sedizorin Chemical_Formula


Sedizorin RX_link

No information avaliable

Sedizorin fda sheet

Sedizorin msds (material safety sheet)

Sedizorin MSDS

Sedizorin Synthesis Reference

Hoerlein, U.S. Pat. 1,025,872 (1912)

Sedizorin Molecular Weight

232.235 g/mol

Sedizorin Melting Point

174 oC

Sedizorin H2O Solubility

<0.01 g/100 mL

Sedizorin State


Sedizorin LogP


Sedizorin Dosage Forms

Tablet; Elixir

Sedizorin Indication

For the treatment of Epilepsy

Sedizorin Pharmacology

Phenobarbital, the longest-acting barbiturate, is used for its anticonvulsant and sedative-hypnotic properties in the management of all seizure disorders except absence (petit mal).

Sedizorin Absorption

Absorbed in varying degrees following oral, rectal or parenteral administration. The salts are more rapidly absorbed than are the acids. The rate of absorption is increased if the sodium salt is ingested as a dilute solution or taken on an empty stomach

Sedizorin side effects and Toxicity

CNS and respiratory depression which may progress to Cheyne-Stokes respiration, areflexia, constriction of the pupils to a slight degree (though in severe poisoning they may wshow paralytic dilation), oliguria, tachycardia, hypotension, lowered body temperature, and coma. Typical shock syndrome (apnea, circulatory collapse, respiratory arrest, and death) may occur.

Sedizorin Patient Information


Practitioners should give the following information and instructions to patients receiving barbiturates:

1. The use of phenobarbital carries with it an associated risk of psychological and/or physical dependence.
The patient should be warned against increasing the dose of the drug without consulting a physician.

2. Phenobarbital may impair mental and/or physical abilities required for the performance of potentially
hazardous tasks (e.g., driving, operating machinery, etc.).

3. Alcohol should not be consumed while taking phenobarbital. Concurrent use of phenobarbital with other
CNS depressants (e.g., alcohol, narcotics, tranquilizers, and antihistamines) may result in additional CNS

Sedizorin Organisms Affected

Humans and other mammals